Research at the Weizmann Institute of Science has led to improved health and better medicine for people everywhere. Weizmann scientists discovered the basis of amniocentesis and new fertility treatments; discovered Copaxone® and Rebif®, today two of the frontline treatments for multiple sclerosis (MS); and developed a technology used in advanced medical imaging scans. They are creating diabetes vaccines and flu vaccines; using stem cells to grow new organs and T cells to treat damaged spines; and studying the origins of life and the origins of disease. Institute scientists are also advancing into the future of medicine: at its new Nancy and Stephen Grand Israel National Center for Personalized Medicine, treatments and therapies designed just for the patient will become a reality. From understanding the origins of disease to developing the basis for new medicines, the Institute’s basic science research is leading to a healthier world.